Dow Up0.00% Nasdaq Up0.09%

Genomic Health Inc. (GHDX)

-NasdaqGS
33.26 Up 0.89(2.75%) Nov 28, 1:00PM EST
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.7
Mean Recommendation (last week):2.7
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:31.73
Median Target:31.50
High Target:40.00
Low Target:20.00
No. of Brokers:12

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Feb 21, 2012GARP ResearchDowngradeBuyNeutral
Feb 8, 2012MLV & CoDowngradeBuyHold
Nov 2, 2011Ladenburg ThalmannUpgradeNeutralBuy
Oct 5, 2011OppenheimerInitiated Perform
Feb 9, 2011Ladenburg ThalmannDowngradeBuyNeutral
Nov 16, 2010Canaccord GenuityInitiated Hold
Apr 21, 2010RBC Capital MktsInitiated Sector Perform
Apr 14, 2010William BlairInitiated Mkt Perform
Jan 22, 2010Piper JaffrayUpgradeNeutralOverweight
Jan 21, 2010Jefferies & CoInitiated Hold

More Upgrades & Downgrades for GHDX

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy3333
Buy2223
Hold6666
Underperform4444
Sell0000

Data provided by Thomson/First Call


Currency in USD.